Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00636181 · ClinicalTrials.gov registry record · NA

Positive Pressure Treatment of Obstructive Sleep Apnea

A NA study of Obstructive Sleep Apnea, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
168
Enrollment target
5
Study locations

NCT00636181: Completed NA study of Obstructive Sleep Apnea, sponsored by Philips Respironics.

NCT00636181 is a NA study of Obstructive Sleep Apnea that has completed, run by Philips Respironics. The registered enrollment target is 168 participants, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (24% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00636181, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
168 participants
Enrollment target
5
Study locations

Study Summary

Six month at home positive pressure therapy study; which mode of therapy will lead to better adherence and patient outcomes?

Primary Outcome

The Apnea-Hyopnea Index is the number of average number of apneas (complete pauses in breathing lasting at least 10 seconds) and hypopneas (decreases in airflow lasting at least 10 seconds) per hour of sleep. This data was compared from the polysomnography (sleep study) data after the first night of device use and at 180 days

Conditions Studied

Interventions

  • DEVICE CPAP
  • DEVICE Auto AFlex
  • DEVICE Auto CPAP

Study Locations (5)

Alabama

  • Sleep Disorders Center of Alabama - Birmingham

California

  • Stanford University - Stanford

Connecticut

  • Gaylord Hospital - New Haven

Florida

  • University of Florida - Gainesville

Other

  • Charite Universitatsmedizin Berlin - Berlin

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2008-01
Est. Completion 2009-03
Phase NA
Philips Respironics

35 total trials

What the finished NCT00636181 record still lists

NCT00636181 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which CPAP is the first listed.

NCT00636181 lists 5 locations in 5 states (Alabama, California, Connecticut).

Frequently Asked Questions

What is clinical trial NCT00636181 about?

NCT00636181 is a clinical study titled "Positive Pressure Treatment of Obstructive Sleep Apnea". Six month at home positive pressure therapy study; which mode of therapy will lead to better adherence and patient outcomes?

What is the current status of trial NCT00636181?

This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2008-01. Estimated completion is 2009-03.

What conditions does trial NCT00636181 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT00636181?

The interventions under investigation include: CPAP (DEVICE), Auto AFlex (DEVICE), Auto CPAP (DEVICE).

Who is sponsoring clinical trial NCT00636181?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00636181 being conducted?

This trial has 5 study locations across Alabama, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00636181's enrollment target sits among peer trials

168 46th of 155 higher than 110 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00636181, the US trial registry maintained by the National Library of Medicine. NCT00636181 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.